NfL as a biomarker for neurodegeneration and survival in Parkinson disease.

David BäckströmJan LinderSusanna Jakobson MoKatrine RiklundHenrik ZetterbergKaj BlennowLars ForsgrenNiklas Lenfeldt
Published in: Neurology (2020)
This study provides Class II evidence that in patients with PD, cNfL concentrations are associated with more severe disease and shorter survival.